Modified proposed guidelines for combining different criteria to classify SCN1A missense variants in the context of the molecular diagnosis of patients with Dravet syndrome variants into “pathogenic” or “likely pathogenic” and correspondent scores. Here, SCN1A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.